International

International regulators, standards and policy-making bodies play a central role in shaping global healthcare. MedTech Europe engages with stakeholders and decision-makers around the world on issues of common interest.

Medical technology companies operate in diverse global markets. Specific insights on regulatory, ethical and procurement environment are essential to expanding to new markets.

Through our advocacy efforts, technical expertise, and holistic approach, MedTech Europe actively engages on many international issues of relevance for the medical technology sector.

As a global industry, trade negotiations and customs rules play an important role in bringing medical technologies to customers and patients around the world. MedTech Europe is actively engaged in trade and customs issues at European and international level.

Brexit is a critical topic for the medical technology industry which has developed highly complex ties between the United Kingdom (UK) and the rest of the EU. Medical technologies are often moved between different EU countries during their production lifecycle and their clinical use. Crucially, up to 30% of our industry’s products have been authorised via UK Notified Bodies (CE marking) and could lose such authorisation overnight in the case of a “cliff edge” Brexit. MedTech Europe is tracking developments closely and has produced a position paper and other relevant documents to help medical technology companies to navigate Brexit.